Current clinical practice guidelines from organizations such as the American Association of Clinical Endocrinology (AACE), the Endocrine Society, and the American Diabetes Association (ADA) support long-term use of anti-obesity medications when clinically indicated
Research from Nature Metabolism shows that beta-arrestin1, a protein that normally limits the insulin response to GLP-1, does not limit the insulin response to GIP or tirzepatide
Of these, 1,180 participants were excluded for the following reasons: initiation during hospitalization, initiation at another institution, having received only a single prescription for oral semaglutide, initiation at a dose other than 3 mg, treatment duration of less than 180 days, missing baseline laboratory data, changes in concomitant oral antidiabetic drugs, or prior use of injectable GLP-1 RAs
Wait 30 minutes to eat, drink, or take other oral medications
If you lose weight rapidly, you have an increased risk of gallstones or gallbladder inflammation
Semaglutide GLP-1 is a gradual-acting medication, and with patience and our ongoing support, you can achieve meaningful, lasting improvements in your health and wellbeing